Use of transoesophageal echocardiography to detect left atrial thrombi before percutaneous balloon dilatation of the mitral valve: a prospective study.
Open Access
- 1 February 1992
- Vol. 67 (2) , 170-173
- https://doi.org/10.1136/hrt.67.2.170
Abstract
OBJECTIVE--Systemic emboli related to atrial thrombi are a well known complication of percutaneous balloon dilatation of the mitral valve. The presence of left atrial thrombi therefore, is believed to be a contraindication to balloon dilatation. The purpose of this study was to determine the frequency of left atrial thrombi in patients referred for balloon dilatation of the mitral valve, the added benefit of pre-procedural transoesophageal echocardiography, and to identify factors that predicted left atrial thrombi. DESIGN--Prospective study over a 14 month period of 20 consecutive patients by cross sectional transthoracic echocardiography 24-48 hours before balloon dilatation of the mitral valve and by transoesophageal echocardiography immediately before the procedure. RESULTS--One patient had a left atrial thrombus detected by transthoracic study. Two patients (10%) had left atrial thrombi identified by transoesophageal echocardiography. In both valve dilatation was not attempted and the thrombi were confirmed at surgery. The remaining 18 patients all underwent successful balloon dilatation of the mitral valve without clinical evidence of an embolic event. No association was found between patient age, mitral valve area, transmitral gradient, left atrial size, presence of atrial fibrillation, severity of mitral regurgitation, cardiac output, or the presence of left atrial swirling and an increased prevalence of atrial thrombi. CONCLUSION--Left atrial thrombi are often seen despite long term systemic anticoagulation in patients referred for balloon dilatation of the mitral valve. The frequency of unsuspected left atrial thrombi detected by transoesophageal echocardiography was similar to the reported frequency of embolic events after balloon dilatation of the mitral valve. Transoesophageal echocardiography for the identification of left atrial thrombi is strongly recommended in all patients before balloon dilatation of the mitral valve including those treated with systemic anticoagulation and those who have had a normal transthoracic echocardiographic study.Keywords
This publication has 14 references indexed in Scilit:
- Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiologyPublished by Elsevier ,2010
- Prevalence and clinical implications of atrial spontaneous contrast in patients undergoing transesophageal echocardiographyThe American Journal of Cardiology, 1990
- Results of percutaneous mitral commissurotomy in 200 patientsThe American Journal of Cardiology, 1989
- Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation.Heart, 1988
- Left atrial spontaneous echo contrast in mitral valve disease: An indicator for an increased thromboembolic riskJournal of the American College of Cardiology, 1988
- Noninvasive assessment of mitral stenosis before and after percutaneous balloon mitral valvuloplastyThe American Journal of Cardiology, 1988
- Balloon dilation of mitral stenosis in adult patients: Postmortem and percutaneous mitral valvuloplasty studiesJournal of the American College of Cardiology, 1987
- Transesophageal two-dimensional echocardiography for the detection of left atrial appendage thrombusJournal of the American College of Cardiology, 1986
- Two-dimensional echocardiographic diagnosis of left-atrial thrombus in rheumatic heart disease. A clinicopathologic study.Circulation, 1983
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978